 | • レポートコード：MRC2-11QY02682 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は動脈血栓症薬のグローバル市場について調査・分析したレポートです。種類別（AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別動脈血栓症薬の競争状況、市場シェア ・世界の動脈血栓症薬市場：種類別市場規模 2015年-2020年（AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他） ・世界の動脈血栓症薬市場：種類別市場規模予測 2021年-2026年（AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他） ・世界の動脈血栓症薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の動脈血栓症薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の動脈血栓症薬市場分析：米国、カナダ ・ヨーロッパの動脈血栓症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの動脈血栓症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の動脈血栓症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの動脈血栓症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma Inc.、Bayer AG、Bristol-Myers Squibb Company、Eisai、Johnson & Johnson、Sanofi、Thromboserin Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Arterial Thrombosis Drug Market
The global Arterial Thrombosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Arterial Thrombosis Drug Scope and Market Size
Arterial Thrombosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Arterial Thrombosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Arterial Thrombosis Drug market is segmented into
AS-1468240
ASP-6537
BAY-1213790
BMS-65445
Others
Segment by Application, the Arterial Thrombosis Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Arterial Thrombosis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Arterial Thrombosis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Arterial Thrombosis Drug Market Share Analysis
Arterial Thrombosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Arterial Thrombosis Drug business, the date to enter into the Arterial Thrombosis Drug market, Arterial Thrombosis Drug product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc.
Bayer AG
Bristol-Myers Squibb Company
Eisai
Johnson & Johnson
Sanofi
Thromboserin Ltd
…
1 Study Coverage
1.1 Arterial Thrombosis Drug Product Introduction
1.2 Market Segments
1.3 Key Arterial Thrombosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Arterial Thrombosis Drug Market Size Growth Rate by Type
1.4.2 AS-1468240
1.4.3 ASP-6537
1.4.4 BAY-1213790
1.4.5 BMS-65445
1.4.6 Others
1.5 Market by Application
1.5.1 Global Arterial Thrombosis Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Arterial Thrombosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Arterial Thrombosis Drug Revenue 2015-2026
2.1.2 Global Arterial Thrombosis Drug Sales 2015-2026
2.2 Global Arterial Thrombosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Arterial Thrombosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Arterial Thrombosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Arterial Thrombosis Drug Competitor Landscape by Players
3.1 Arterial Thrombosis Drug Sales by Manufacturers
3.1.1 Arterial Thrombosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Arterial Thrombosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Arterial Thrombosis Drug Revenue by Manufacturers
3.2.1 Arterial Thrombosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Arterial Thrombosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Arterial Thrombosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Arterial Thrombosis Drug Revenue in 2019
3.2.5 Global Arterial Thrombosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Arterial Thrombosis Drug Price by Manufacturers
3.4 Arterial Thrombosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Arterial Thrombosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Arterial Thrombosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Arterial Thrombosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Arterial Thrombosis Drug Market Size by Type (2015-2020)
4.1.1 Global Arterial Thrombosis Drug Sales by Type (2015-2020)
4.1.2 Global Arterial Thrombosis Drug Revenue by Type (2015-2020)
4.1.3 Arterial Thrombosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Arterial Thrombosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Arterial Thrombosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Arterial Thrombosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Arterial Thrombosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Arterial Thrombosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Arterial Thrombosis Drug Market Size by Application (2015-2020)
5.1.1 Global Arterial Thrombosis Drug Sales by Application (2015-2020)
5.1.2 Global Arterial Thrombosis Drug Revenue by Application (2015-2020)
5.1.3 Arterial Thrombosis Drug Price by Application (2015-2020)
5.2 Arterial Thrombosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Arterial Thrombosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Arterial Thrombosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Arterial Thrombosis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Arterial Thrombosis Drug by Country
6.1.1 North America Arterial Thrombosis Drug Sales by Country
6.1.2 North America Arterial Thrombosis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Arterial Thrombosis Drug Market Facts & Figures by Type
6.3 North America Arterial Thrombosis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Arterial Thrombosis Drug by Country
7.1.1 Europe Arterial Thrombosis Drug Sales by Country
7.1.2 Europe Arterial Thrombosis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Arterial Thrombosis Drug Market Facts & Figures by Type
7.3 Europe Arterial Thrombosis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Arterial Thrombosis Drug by Region
8.1.1 Asia Pacific Arterial Thrombosis Drug Sales by Region
8.1.2 Asia Pacific Arterial Thrombosis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Arterial Thrombosis Drug Market Facts & Figures by Type
8.3 Asia Pacific Arterial Thrombosis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Arterial Thrombosis Drug by Country
9.1.1 Latin America Arterial Thrombosis Drug Sales by Country
9.1.2 Latin America Arterial Thrombosis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Arterial Thrombosis Drug Market Facts & Figures by Type
9.3 Central & South America Arterial Thrombosis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Arterial Thrombosis Drug by Country
10.1.1 Middle East and Africa Arterial Thrombosis Drug Sales by Country
10.1.2 Middle East and Africa Arterial Thrombosis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Arterial Thrombosis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Arterial Thrombosis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Arterial Thrombosis Drug Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Description and Business Overview
11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer AG Arterial Thrombosis Drug Products Offered
11.2.5 Bayer AG Related Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Description and Business Overview
11.3.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Company Arterial Thrombosis Drug Products Offered
11.3.5 Bristol-Myers Squibb Company Related Developments
11.4 Eisai
11.4.1 Eisai Corporation Information
11.4.2 Eisai Description and Business Overview
11.4.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eisai Arterial Thrombosis Drug Products Offered
11.4.5 Eisai Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Arterial Thrombosis Drug Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Arterial Thrombosis Drug Products Offered
11.6.5 Sanofi Related Developments
11.7 Thromboserin Ltd
11.7.1 Thromboserin Ltd Corporation Information
11.7.2 Thromboserin Ltd Description and Business Overview
11.7.3 Thromboserin Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Thromboserin Ltd Arterial Thrombosis Drug Products Offered
11.7.5 Thromboserin Ltd Related Developments
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Arterial Thrombosis Drug Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Arterial Thrombosis Drug Market Estimates and Projections by Region
12.1.1 Global Arterial Thrombosis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Arterial Thrombosis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Arterial Thrombosis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Arterial Thrombosis Drug Sales Forecast (2021-2026)
12.2.2 North America: Arterial Thrombosis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Arterial Thrombosis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Arterial Thrombosis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Arterial Thrombosis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Arterial Thrombosis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Arterial Thrombosis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Arterial Thrombosis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Arterial Thrombosis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Arterial Thrombosis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Arterial Thrombosis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Arterial Thrombosis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Arterial Thrombosis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Arterial Thrombosis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Arterial Thrombosis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Arterial Thrombosis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Arterial Thrombosis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Arterial Thrombosis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Arterial Thrombosis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Arterial Thrombosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Arterial Thrombosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Arterial Thrombosis Drug Market Segments
Table 2. Ranking of Global Top Arterial Thrombosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Arterial Thrombosis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AS-1468240
Table 5. Major Manufacturers of ASP-6537
Table 6. Major Manufacturers of BAY-1213790
Table 7. Major Manufacturers of BMS-65445
Table 8. Major Manufacturers of Others
Table 9. Global Arterial Thrombosis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Arterial Thrombosis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Arterial Thrombosis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Arterial Thrombosis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Arterial Thrombosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Arterial Thrombosis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Arterial Thrombosis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Arterial Thrombosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Arterial Thrombosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arterial Thrombosis Drug as of 2019)
Table 18. Arterial Thrombosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Arterial Thrombosis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Arterial Thrombosis Drug Price (2015-2020) (USD/Pcs)
Table 21. Arterial Thrombosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Arterial Thrombosis Drug Product Type
Table 23. Date of International Manufacturers Enter into Arterial Thrombosis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Arterial Thrombosis Drug Sales Share by Type (2015-2020)
Table 27. Global Arterial Thrombosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Arterial Thrombosis Drug Revenue Share by Type (2015-2020)
Table 29. Arterial Thrombosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Arterial Thrombosis Drug Sales Share by Application (2015-2020)
Table 32. North America Arterial Thrombosis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Arterial Thrombosis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Arterial Thrombosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Arterial Thrombosis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Arterial Thrombosis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Arterial Thrombosis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Arterial Thrombosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Arterial Thrombosis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Arterial Thrombosis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Arterial Thrombosis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Arterial Thrombosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Arterial Thrombosis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Arterial Thrombosis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Arterial Thrombosis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Arterial Thrombosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Arterial Thrombosis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Arterial Thrombosis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Arterial Thrombosis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Arterial Thrombosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Arterial Thrombosis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Arterial Thrombosis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Arterial Thrombosis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Table 72. Astellas Pharma Inc. Corporation Information
Table 73. Astellas Pharma Inc. Description and Major Businesses
Table 74. Astellas Pharma Inc. Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Astellas Pharma Inc. Product
Table 76. Astellas Pharma Inc. Recent Development
Table 77. Bayer AG Corporation Information
Table 78. Bayer AG Description and Major Businesses
Table 79. Bayer AG Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bayer AG Product
Table 81. Bayer AG Recent Development
Table 82. Bristol-Myers Squibb Company Corporation Information
Table 83. Bristol-Myers Squibb Company Description and Major Businesses
Table 84. Bristol-Myers Squibb Company Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bristol-Myers Squibb Company Product
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Eisai Corporation Information
Table 88. Eisai Description and Major Businesses
Table 89. Eisai Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Eisai Product
Table 91. Eisai Recent Development
Table 92. Johnson & Johnson Corporation Information
Table 93. Johnson & Johnson Description and Major Businesses
Table 94. Johnson & Johnson Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Recent Development
Table 97. Sanofi Corporation Information
Table 98. Sanofi Description and Major Businesses
Table 99. Sanofi Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Sanofi Product
Table 101. Sanofi Recent Development
Table 102. Thromboserin Ltd Corporation Information
Table 103. Thromboserin Ltd Description and Major Businesses
Table 104. Thromboserin Ltd Arterial Thrombosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Thromboserin Ltd Product
Table 106. Thromboserin Ltd Recent Development
Table 107. Global Arterial Thrombosis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Arterial Thrombosis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Arterial Thrombosis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Arterial Thrombosis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Arterial Thrombosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Arterial Thrombosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Arterial Thrombosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Arterial Thrombosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Arterial Thrombosis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Arterial Thrombosis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Arterial Thrombosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Arterial Thrombosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Arterial Thrombosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Arterial Thrombosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Arterial Thrombosis Drug Players
Table 125. Arterial Thrombosis Drug Customers List
Table 126. Arterial Thrombosis Drug Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Arterial Thrombosis Drug Product Picture
Figure 2. Global Arterial Thrombosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AS-1468240 Product Picture
Figure 4. ASP-6537 Product Picture
Figure 5. BAY-1213790 Product Picture
Figure 6. BMS-65445 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Arterial Thrombosis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Arterial Thrombosis Drug Report Years Considered
Figure 13. Global Arterial Thrombosis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Arterial Thrombosis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Arterial Thrombosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Arterial Thrombosis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Arterial Thrombosis Drug Sales Market Share by Region in 2019
Figure 18. Global Arterial Thrombosis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Arterial Thrombosis Drug Revenue Market Share by Region in 2019
Figure 20. Global Arterial Thrombosis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Arterial Thrombosis Drug Revenue in 2019
Figure 22. Arterial Thrombosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Arterial Thrombosis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Arterial Thrombosis Drug Sales Market Share by Type in 2019
Figure 25. Global Arterial Thrombosis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Arterial Thrombosis Drug Revenue Market Share by Type in 2019
Figure 27. Global Arterial Thrombosis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Arterial Thrombosis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Arterial Thrombosis Drug Sales Market Share by Application in 2019
Figure 30. Global Arterial Thrombosis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Arterial Thrombosis Drug Revenue Market Share by Application in 2019
Figure 32. North America Arterial Thrombosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Arterial Thrombosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Arterial Thrombosis Drug Sales Market Share by Country in 2019
Figure 35. North America Arterial Thrombosis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Arterial Thrombosis Drug Market Share by Type in 2019
Figure 41. North America Arterial Thrombosis Drug Market Share by Application in 2019
Figure 42. Europe Arterial Thrombosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Arterial Thrombosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Arterial Thrombosis Drug Sales Market Share by Country in 2019
Figure 45. Europe Arterial Thrombosis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Arterial Thrombosis Drug Market Share by Type in 2019
Figure 57. Europe Arterial Thrombosis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Arterial Thrombosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Arterial Thrombosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Arterial Thrombosis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Arterial Thrombosis Drug Revenue Market Share by Region in 2019
Figure 62. China Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Arterial Thrombosis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Arterial Thrombosis Drug Market Share by Application in 2019
Figure 86. Latin America Arterial Thrombosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Arterial Thrombosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Arterial Thrombosis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Arterial Thrombosis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Arterial Thrombosis Drug Market Share by Type in 2019
Figure 97. Latin America Arterial Thrombosis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Arterial Thrombosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Arterial Thrombosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Arterial Thrombosis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Arterial Thrombosis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Arterial Thrombosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Arterial Thrombosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Arterial Thrombosis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Arterial Thrombosis Drug Market Share by Application in 2019
Figure 110. North America Arterial Thrombosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Arterial Thrombosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Arterial Thrombosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Arterial Thrombosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Arterial Thrombosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Arterial Thrombosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Arterial Thrombosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Arterial Thrombosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Arterial Thrombosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Arterial Thrombosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…- 3D動脈スピンラベリング（3D ASL）の世界市場（～2026年） Market Analysis and Insights: Global 3D Arterial Spin Labeling (3D ASL) Market The global 3D Arterial Spin Labeling (3D ASL) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global 3D Arterial Spin Labeling (3D ASL) Scope and …
- 肺動脈性肺高血圧症（PAH）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Arterial Hypertension (PAH) S…
- 末梢動脈疾患（PAD）薬の世界市場（～2026年） Market Analysis and Insights: Global Peripheral Arterial Disease (PAD) Drugs Market The global Peripheral Arterial Disease (PAD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peripheral Arterial Disease (PAD) D…
- 末梢動脈疾患（PAD）治療薬の世界市場（～2026年） Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the…